BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help
Search Results
Documents 1-2 out of 2 found
  Current Search:  tekturna: 2     
HTML
100%
Novartis Pays $185M Fine For Off-Label Marketing
The drugmaker is pleading guilty to a misdemeanor to resolve criminal allegations for improperly promoting its Trileptal epilepsy med.

Since 2005, the US Attorney in Phildelphia has pursued civil and criminal investigations into off-label marketing and eyed...

Cafepharma:  Jan 28 2010 8:55PM
Matching: tekturna 		Find similar documents
HTML
100%
Novartis AG (NYSE:NVS) Company performance exceeds our expectation in 4Q 09.
Novartis AG (Novartis) reported significant growth in total revenues in 4Q 09, exceeding our expectations.

EBITDA margin as well as net margin exceeded our expectations in 4Q 09.

We maintain our positive growth outlook for the company's Pharmaceutical...

Research Oracle:  Jan 27 2010 2:02PM
Matching: tekturna 		Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.